LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Clinical trials for LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC explained in plain language.
Never miss a new study
Get alerted when new LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC trials appear
Sign up with your email to follow new studies for LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for rare immune overreaction disease
Disease control Recruiting nowThis study tests a drug called golidocitinib for people with hemophagocytic lymphohistiocytosis (HLH), a rare condition where the immune system attacks the body. About 28 adults aged 14 to 70 with new or returning HLH will take the drug alone. The goal is to see if it can normali…
Matched conditions: LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
Scientists investigate mysterious immune disease to find better ways to diagnose it
Knowledge-focused Recruiting nowThis study aims to understand why some adults develop a severe immune condition called secondary hemophagocytic lymphohistiocytosis (sHLH), which causes dangerous fevers and inflammation. Researchers will follow 300 adults with sHLH for up to a year, collecting blood samples and …
Matched conditions: LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC